Feasibility of novel endoscopic imaging techniques during transbronchial lung biopsy in interstitial lung disease

Not Applicable

• Conditions: Interstitial lung disease; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12622001215718
• Lead Sponsor: Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-09-09
• Last Update Posted: 19 September 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Adults aged 18 years or older
- Working diagnosis of unclassifiable interstitial lung disease or a low confidence diagnosis
- Referred for cryobiopsy following discussion at an ILD multidisciplinary meeting

Exclusion Criteria

•Reduced lung function (FVC less than 50% predicted; or FEV1 less than 50% predicted or less than 0.8L; or DLCO less than 50% predicted or less than 35 units)
•Uncontrolled bleeding diathesis
•American Society of Anesthesiology Status of III or higher
•Hypoxaemia (PaO2 less than 55 to 60mmHg on room air or while receiving 2L/minute nasal oxygen)
•Pulmonary hypertension (sPAP greater than 50mmHg)
•Body mass index greater than 35kg/m2
•Inability to give informed consent
•Vulnerable population (inability to understand English, pregnant women, prisoner)

Study & Design

• Study Type: Interventional
• Study Design: Not specified